Bing Wang

BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency

Yuqiao Shen, Farah Rehman, Ying Feng et al. · Clinical Cancer Research · 2013 · 487 citations · Full text

Medicine, Oncology, Pharmacology +14

Trapping Poly(ADP-Ribose) Polymerase

Yuqiao Shen, Mika Aoyagi-Scharber, Bing Wang · Journal of Pharmacology and Experimental Therapeutics · 2015 · 231 citations

Life Sciences, Oncology, Pharmacology +15

Carbon Monoxide–Activated Nrf2 Pathway Leads to Protection Against Permanent Focal Cerebral Ischemia

Bing Wang, Wangsen Cao, Shyam Biswal et al. · Stroke · 2011 · 190 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Structural Characteristics of Lignin Macromolecules from Different <i>Eucalyptus</i> Species

Han-Min Wang, Bing Wang, Jia‐Long Wen et al. · ACS Sustainable Chemistry & Engineering · 2017 · 184 citations

Life Sciences, Biochemistry, Plant Sciences +14

Discovery and Characterization of (8<i>S</i>,9<i>R</i>)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1<i>H</i>-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3<i>H</i>-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent

Bing Wang, Daniel I. Chu, Ying Feng et al. · Journal of Medicinal Chemistry · 2015 · 170 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11